Call Us Toll Free: 1-800-388-9993

 

A reliable investment strategy: Identify a widely diversified portfolio of high-quality stocks and build up additional holdings at favorable prices.

 

DRIPs can help you do that.

 

Even small investors can follow such a strategy by investing through dividend reinvestment plans (DRIPs). That's because it takes ownership of only a single share of company stock to establish an account. Therefore, there is nothing to stop you from buying companies in a variety of industries.

 

As for buying at favorable prices, dollar-cost averaging virtually assures that you will buy most shares at favorable prices. And DRIPs provide an excellent way to dollar-cost average. These plans allow you to invest cash amounts to buy shares directly from the company. Once you are enrolled in a plan, you can invest amounts of as little as $25 or $50 (or many thousands of dollars) to buy shares or fractions of shares. That's different than the traditional way to invest, which is to pay brokerage fees to buy a certain number of shares.

 

 

AbbVie Inc. (ABBV)

Available from the Temper Enrollment Service: Yes


Last Update On: 07/30/2018:

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company offers HUMIRA, a biologic therapy administered as a subcutaneous injection for autoimmune diseases IMBRUVICA, an oral therapy for patients with chronic lymphocytic leukemia and VIEKIRA PAK, an interferon-free therapy, with or without ribavirin, for the treatment of adults with genotype 1 chronic hepatitis C. It also provides Kaletra, an anti- human immunodeficiency virus (HIV)-1 medicine used with other anti-HIV-1 medications as a treatment that maintains viral suppression in HIV-1 patients Norvir, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1 and Synagis to prevent RSV infection at-risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males diagnosed with symptomatic low testosterone Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency Synthroid to treat hypothyroidism and Lupron, a product for the palliative treatment of prostate cancer, endometriosis, and central precocious puberty, as well as for the treatment of patients with anemia. Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease Sevoflurane, an anesthesia product for human use and ZINBRYTA, a subcutaneous treatment for relapsing forms of multiple sclerosis. It serves wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. AbbVie Inc. has a collaboration with Alector, Inc. C2N Diagnostics Voyager Therapeutics, Inc. Janssen Biotech, Inc. International Myeloma Foundation Calibr and Scripps Research The Institute for Research in Immunology and Cancer ? Commercialization of Research and the Université de Montréal. The company was incorporated in 2012 and is based in North Chicago, Illinois.**Taken from Yahoo Finance**

Industry: Drugs, health care
Minimum Investment: $25.00
Maximum Investment: $150,000/year
Shares to qualify: 1
Recent Price: 86.96
Investing Fee: $0!
Fee for Dividends: $0!

! = Company pays fees

Information is based on an annual survey and updated when company changes become available.

Click for Español

FOR MORE
INFORMATION

And a free copy of The Moneypaper's direct investing brochure, please enter your contact information below.

You will also be signed up to receive our monthly stock special.

You can unsubscribe at any time. We do not share your email with anyone.

By email, you get the Monthly “Stock Special,” where the service fee for enrollment in a great DRIP stock is reduced.

* Required Field.